Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia
Non-Hodgkin's Lymphoma
Non-Hodgkin Lymphoma
Hodgkin Disease
Hodgkins Disease
Hodgkin's Disease
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Neoplasm

Interventions

DRUG: BL-8040
PROCEDURE: Leukapheresis
PROCEDURE: Hematopoietic cell transplant

Sponsor

Washington University School of Medicine

Collaborators

[object Object]